Inactive Instrument

Hemagen Diagnostics, Inc. Stock Other OTC

Equities

HMGN

US4235011057

Medical Equipment, Supplies & Distribution

Sales 2011 5.14M Sales 2012 4.04M Capitalization 543K
Net income 2011 - Net income 2012 - EV / Sales 2011 0.97 x
Net Debt 2011 4.51M Net Debt 2012 4.96M EV / Sales 2012 1.36 x
P/E ratio 2011
-0.5 x
P/E ratio 2012
-0.58 x
Employees -
Yield 2011 *
-
Yield 2012
-
Free-Float 99.36%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 61 99-09-30
Director of Finance/CFO 54 13-01-08
Members of the board TitleAgeSince
Chief Executive Officer 61 99-09-30
More insiders
Hemagen Diagnostics, Inc. is engaged in providing clinical diagnostic solutions. The Company is primarily focused on Veterinary Clinical Diagnostics. It is also focused on VIRGO, its Human Clinical Diagnostic line of autoimmune and infectious disease products. The Company develops, manufactures and markets a range of test kits used to aid in the diagnosis of certain autoimmune and infectious diseases. The Company’s autoimmune product portfolio includes Hemagen DNA Kit, Hemagen Rheumatoid Factor Kit, VIRGO AMA IgG, VIRGO ANA/Hep-2 IgG, VIRGO Anti-nDNA IgG, VIRGO cANCA (PR-3) Kit, VIRGO dsDNA Kit, VIRGO ENA Screen 6 Kit, VIRGO ENA Screening, VIRGO ENA Series, VIRGO pANCA myeloperoxidase (MPO) Kit and VIRGO Rheumatoid Factor Kit. It offers various products for infectious disease, which includes VIRGO C. trach IgG, VIRGO CMV IgG and VIRGO epstein-barr virus (EBV)- viral capsid antigen (VCA) IgG. Its products are used in laboratories, hospitals and blood banks around the world.
More about the company